TABLE 1.
Group | In-house screening IgM ELISA
|
No. with in-house modified IgM ELISA index:
|
||||
---|---|---|---|---|---|---|
Index | n | <1.00 | 1.00-2.00 | 2.01-3.00 | >3.00 | |
Nonreactive in CDC/SPHL screening assay | 0.90-1.10 | 6 | 6 | |||
1.11-2.00 | 38 | 29 | 7 | 2 | ||
2.01-3.00 | 15 | 9 | 3 | 3 | ||
>3.00 | 11 | 5 | 2 | 1 | 3 | |
Total for nonreactive samples | 70 | 49 | 12 | 6 | 3 | |
Reactive in CDC/SPHL screening assay | 0.90-1.10 | 1 | 1 | |||
1.11-2.00 | 11 | 2 | 6 | 3 | ||
2.01-3.00 | 7 | 2 | 3 | 2 | ||
>3.00 | 35 | 3 | 32 | |||
Total for reactive samples | 54 | 3 | 8 | 9 | 34 |